Moreover, in a retrospective study it was shown in almost 1000 patients that immunotherapy with anti-PD-1 (Programmed cell death protein 1) is particularly recommended for melanomas originating from chronically sun-exposed areas [20]. The gene discussed is PDCD1; the disease is melanoma.